Navigation Links
Spectral OCT/SLO

ProductsSpectral OCT/SLO
Company OTI Ophthalmic Technologies Inc.
Item Spectral OCT/SLO
Features 
  • High Speed Scanning of optical coherence tomography (OCT) images up to 50 times faster than time domain
  • Ultra High resolution imaging of 5-6 microns
  • Simultaneous SLO imaging for real time registration and orientation
  • Accurate and easy reproducibily with SLO imaging
  • Real-Time Cross-Sectional OCT and SLO image
  • Horizontal and Vertical Views, split screen with SLO, black and white, colour
  • Accurate registration of 3D information
  • Line scan, automatic raster scan, radial scan modes
  • Advanced 3D Topgraphic and Tomographic Measurements and Comparisons
  • RNFL and Optic Nerve Thickness and Volume Measurements for Glaucoma
  • Affordable Multimodality System
  • Microperimetry Option
Description OTI's new Spectral system is a combination Spectral Optical Coherence Tomography (OCT) and Scanning Laser Ophthalmoscope (SLO) system that provides suberb, high-quality images of the vitreo-retina, retina, and choroidal-retina structure. With the advancements of spectral technology, OTI's sytem can reach scanning rates of up to 27,000 A-Scans per second and provide images with a resolution of 5-6 microns.

The unique dual optical coherence tomography (OCT) and SLO imaging of OTI's system provides a confocal fundus image allowing for accurate point to point registration and orientation of the B-Scan image in real-time. Other spectral systems are using 3D reconstructions to help identify the location of the B-Scan, by creating quasi-SLO images from large 3D images. These images, which are rendered and manipulated after the scan, are time consuming, and slow down patient throughput. With OTI's system, this information is available on-screen in real time.

OTI's new system offers a wide range of clincial possiblilities with its ability to provide high resolution B-Scan images, 3D Tomographic and Topographic data, and Optic Nerve and RNFL data for monitoring glaucoma patients. Its ability to fuse with other modalities such as optional Microperimetry make it an affordable, space-saving alternative to purchasing an entirely new system for this function.

Info OTI Ophthalmic Technologies Inc.
Customer Service: (888) 517-4444
Web site: http://www.oti-canada.com

Related medicine products :

1. HearTwave II Microvolt T-Wave Alternans System With Analytic Spectral Method
Other Medicine News:Health News:Medications plus dental materials may equal infection for diabetic patients 2Health News:New AHIP Study in Health Affairs Challenges Previous Assumptions About Medigap's Impact on Medicare Costs 2Health News:New AHIP Study in Health Affairs Challenges Previous Assumptions About Medigap's Impact on Medicare Costs 3Health News:Large Disparities in Kidney Testing Based on Disease, Gender and State, Quest Diagnostics Health Trends(TM) Report Finds 2Health News:Large Disparities in Kidney Testing Based on Disease, Gender and State, Quest Diagnostics Health Trends(TM) Report Finds 3Health News:Large Disparities in Kidney Testing Based on Disease, Gender and State, Quest Diagnostics Health Trends(TM) Report Finds 4Health News:Large Disparities in Kidney Testing Based on Disease, Gender and State, Quest Diagnostics Health Trends(TM) Report Finds 5Health News:Large Disparities in Kidney Testing Based on Disease, Gender and State, Quest Diagnostics Health Trends(TM) Report Finds 6Health News:Large Disparities in Kidney Testing Based on Disease, Gender and State, Quest Diagnostics Health Trends(TM) Report Finds 7Health News:Transplant Network Appoints Cynthia Siljestrom CEO 2Health News:Preschool Intervention Curbed Trend Toward Obesity 2Health News:Preschool Intervention Curbed Trend Toward Obesity 3
Breaking Medicine Technology:Medco, State of Illinois and Community Retail Pharmacies Launch 'Wired' Collaborative Solution to Close Critical Medication-Related Gaps in Healthcare, Improving Outcomes and Lowering Costs 2Medco, State of Illinois and Community Retail Pharmacies Launch 'Wired' Collaborative Solution to Close Critical Medication-Related Gaps in Healthcare, Improving Outcomes and Lowering Costs 3Medco, State of Illinois and Community Retail Pharmacies Launch 'Wired' Collaborative Solution to Close Critical Medication-Related Gaps in Healthcare, Improving Outcomes and Lowering Costs 4Medco, State of Illinois and Community Retail Pharmacies Launch 'Wired' Collaborative Solution to Close Critical Medication-Related Gaps in Healthcare, Improving Outcomes and Lowering Costs 5FDA Launches Orphan Drug Workshop at KGI 2Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 2Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 3Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 4Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 5Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 6Companion Life Adds Dental Tourism Option to Help Policyholders Save 60761 1Companion Life Adds Dental Tourism Option to Help Policyholders Save 60761 2Companion Life Adds Dental Tourism Option to Help Policyholders Save 60761 3SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 14735 1SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 14735 2SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 14735 3SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 14735 4SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 14735 5SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 14735 6SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 14735 7SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 14735 8SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 14735 9SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 14735 10SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 14735 11SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 14735 12SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 14735 13SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 14735 14SpineSmith Partners and GenOsteo Announce Collaborative Product Development Agreement 14733 1SpineSmith Partners and GenOsteo Announce Collaborative Product Development Agreement 14733 2